AttendMe Owl Logo
AttendMe
Evidence Evolution
Cardiothoracic SurgeryCardiothoracic Surgery

How This Evidence Evolved

Lung Cancer Sublobar Resection

Challenging Lobectomy as the Standard of Care for Small Peripheral Non-Small Cell Lung Cancer

21.3

Timeline

Signal

Early observations and pilot data that first suggested a new direction

The Lung Cancer Study Group randomized 276 patients with peripheral T1N0 NSCLC to lobectomy or limited resection, with 247 eligible for analysis. Limited resection was associated with a tripling of local recurrence (P=.008) and no improvement in perioperative morbidity, mortality or late pulmonary function. The report therefore supported lobectomy for its tested population. Limited resection included segment or wedge procedures; the trial did not separately establish the performance of modern segmentectomy in smaller tumors.
Proof

Landmark RCTs and pivotal trials that established the evidence base

JCOG0802 randomized 1,106 patients with clinical stage IA peripheral NSCLC ≤2 cm and consolidation-to-tumor ratio >0.5 to segmentectomy or lobectomy. At median 7.3-year follow-up, 5-year overall survival was 94.3% versus 91.1%, with superiority and noninferiority confirmed. Local relapse was higher after segmentectomy (10.5% vs 5.4%). CALGB 140503 randomized 697 patients with peripheral tumors ≤2 cm after intraoperative confirmation of node-negative disease. Sublobar resection was noninferior for disease-free survival after median 7-year follow-up. Together, the trials support less extensive resection in the tested populations.
Extension

Follow-up studies, subgroup analyses, and real-world validation

JCOG0802 and CALGB 140503 address selected small peripheral tumors. JCOG0802 compared segmentectomy with lobectomy, while CALGB compared sublobar with lobar resection after confirmation of node-negative disease. They do not directly rank segmentectomy against wedge resection. Higher local relapse after segmentectomy in JCOG0802 (10.5% vs 5.4%) coexisted with better overall survival; this does not itself establish that surveillance or salvage treatment caused the survival result.
Now

Current standard of care and ongoing research directions

JCOG0802 and CALGB 140503 support less extensive resection in selected peripheral NSCLC ≤2 cm. JCOG0802 tested segmentectomy; CALGB required intraoperative confirmation of node-negative disease. Questions remain about ground-glass predominance, consolidation-to-tumor ratio and histologic subtype in patient selection, extension to tumors 2–3 cm, and the role of robotic or thoracoscopic segmentectomy.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

What changed to make sublobar resection acceptable after decades of lobectomy being the standard?+
JCOG0802 randomized 1,106 patients and CALGB 140503 randomized 697. In selected peripheral NSCLC ≤2 cm, these trials supported segmentectomy or sublobar resection versus lobectomy. JCOG0802 found better 5-year overall survival with segmentectomy (94.3% vs 91.1%); CALGB required intraoperative confirmation of node-negative disease. Their eligibility criteria matter when applying the findings.
Is segmentectomy preferred over wedge resection?+
JCOG0802 compared segmentectomy with lobectomy; it did not directly test segmentectomy against wedge resection. CALGB 140503 tested sublobar resection.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026